Japan · Delayed Price · Currency is JPY CellSource Statistics
Total Valuation
CellSource has a market cap or net worth of JPY 5.87 billion. The enterprise value is 1.09 billion.
| Market Cap | 5.87B |
| Enterprise Value | 1.09B |
Important Dates
The last earnings date was Wednesday, June 10, 2026.
| Earnings Date | Jun 10, 2026 |
| Ex-Dividend Date | Oct 30, 2025 |
Share Statistics
CellSource has 19.85 million shares outstanding. The number of shares has increased by 1.31% in one year.
| Current Share Class | 19.85M |
| Shares Outstanding | 19.85M |
| Shares Change (YoY) | +1.31% |
| Shares Change (QoQ) | -0.26% |
| Owned by Insiders (%) | 44.26% |
| Owned by Institutions (%) | 3.30% |
| Float | 8.81M |
Valuation Ratios
The trailing PE ratio is 83.83 and the forward PE ratio is 69.65.
| PE Ratio | 83.83 |
| Forward PE | 69.65 |
| PS Ratio | 1.60 |
| PB Ratio | 0.98 |
| P/TBV Ratio | 1.00 |
| P/FCF Ratio | 14.12 |
| P/OCF Ratio | 13.17 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 2.26, with an EV/FCF ratio of 2.62.
| EV / Earnings | 15.55 |
| EV / Sales | 0.30 |
| EV / EBITDA | 2.26 |
| EV / EBIT | 3.94 |
| EV / FCF | 2.62 |
Financial Position
The company has a current ratio of 10.99
| Current Ratio | 10.99 |
| Quick Ratio | 10.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 276.00 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 7.83% |
| Return on Capital Employed (ROCE) | 4.26% |
| Weighted Average Cost of Capital (WACC) | 3.23% |
| Revenue Per Employee | 24.77M |
| Profits Per Employee | 472,973 |
| Employee Count | 148 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, CellSource has paid 125.00 million in taxes.
| Income Tax | 125.00M |
| Effective Tax Rate | 64.10% |
Stock Price Statistics
The stock price has decreased by -57.65% in the last 52 weeks. The beta is -0.19, so CellSource's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | -57.65% |
| 50-Day Moving Average | 350.78 |
| 200-Day Moving Average | 439.07 |
| Relative Strength Index (RSI) | 35.77 |
| Average Volume (20 Days) | 77,395 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CellSource had revenue of JPY 3.67 billion and earned 70.00 million in profits. Earnings per share was 3.53.
| Revenue | 3.67B |
| Gross Profit | 2.11B |
| Operating Income | 276.00M |
| Pretax Income | 195.00M |
| Net Income | 70.00M |
| EBITDA | 481.00M |
| EBIT | 276.00M |
| Earnings Per Share (EPS) | 3.53 |
Balance Sheet
The company has 4.79 billion in cash and n/a in debt, with a net cash position of 4.79 billion or 241.14 per share.
| Cash & Cash Equivalents | 4.79B |
| Total Debt | n/a |
| Net Cash | 4.79B |
| Net Cash Per Share | 241.14 |
| Equity (Book Value) | 5.99B |
| Book Value Per Share | 301.91 |
| Working Capital | 4.98B |
Cash Flow
In the last 12 months, operating cash flow was 446.00 million and capital expenditures -30.00 million, giving a free cash flow of 416.00 million.
| Operating Cash Flow | 446.00M |
| Capital Expenditures | -30.00M |
| Depreciation & Amortization | 205.00M |
| Net Borrowing | 180.00M |
| Free Cash Flow | 416.00M |
| FCF Per Share | 20.96 |
Margins
Gross margin is 57.58%, with operating and profit margins of 7.53% and 1.91%.
| Gross Margin | 57.58% |
| Operating Margin | 7.53% |
| Pretax Margin | 5.32% |
| Profit Margin | 1.91% |
| EBITDA Margin | 13.12% |
| EBIT Margin | 7.53% |
| FCF Margin | 11.35% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 1.69%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 1.69% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 140.00% |
| Buyback Yield | -1.31% |
| Shareholder Yield | 0.31% |
| Earnings Yield | 1.19% |
| FCF Yield | 7.08% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on October 28, 2021. It was a forward split with a ratio of 3.
| Last Split Date | Oct 28, 2021 |
| Split Type | Forward |
| Split Ratio | 3 |
Scores
CellSource has an Altman Z-Score of 8.5 and a Piotroski F-Score of 4.
| Altman Z-Score | 8.5 |
| Piotroski F-Score | 4 |